HIV/AIDS

More from the Series

WORKING PAPERS
Corruption and Averting AIDS Deaths - Working Paper 395
February 25, 2015
This paper looks at the impact of corruption on the effectiveness of antiretroviral drugs in preventing AIDS deaths and the potential channels that generate this relationship. 
Blog Post
Major Progress at the Global Fund: A One-Year ‘More Health for the Money’ Update for World AIDS Day
December 01, 2014
Last September, we released a report on how the Global Fund could get more health for its money. In it, we offered concrete suggestions for improvements in several different value-for-money domains, all with an eye toward maximizing the health impact of every dollar spent.
Blog Post
World AIDS Day 2014: UNAIDS Shifts Its Emphasis toward Reducing New Infections
November 25, 2014
On World AIDS Day in 2003, WHO and UNAIDS launched a campaign called the “3 by 5 initiative,” with the objective to “treat three million people with HIV by 2005.” At that time, AIDS treatment was still prohibitively expensive for poor countries, where only a few thousand peop...
Blog Post
What Can Donors Learn from HIV in Responding to Ebola?
October 23, 2014
Since the first case of Ebola appeared last year, the virus has infected nearly 10,000 people.  The epidemic is concentrated in Liberia, Sierra Leone, and Guinea — post-conflict countries with incredibly weak health systems.
Blog Post
Is PrEP Cost-Effective?
August 06, 2014
As we predicted, this year’s International AIDS Conference featured several presentations on pre-exposure prophylaxis, or PrEP. 
Blog Post
Our Condolences to All Affected by Flight MH17
July 18, 2014
CGD and its health team express our condolences to the families of all lost on MH17. We know that many of those attending the International AIDS Conference, which starts this week-end in Melbourne, have been touched personally by the AIDS researchers and activists lost on the plane and will deeply f...
Blog Post
What to Expect at This Year's International AIDS Conference
July 18, 2014
There’s no doubt that Treatment as Prevention (TasP) will receive continued emphasis at this year’s International Aids Conference (IAC), as advocates argue for aggressively expanding treatment from the 9 million worldwide currently on antiretrovirals (ARVs) to the 35 million people who a...